Study of Dissolution Enhancement of Furosemide by Solid Dispersion Technique Using Different Polymer


Dissolution Enhancement, Excipients, Solid Dosage Form, Furosemide.

How to Cite

Tanvir Halim, Nilufa Haque, Md. Didaruzzaman Sohel, Rajibul Islam Khan, Mohammad Menhaj Ovi, LabibaAmal , & Md. Hassan Kawsar. (2019). Study of Dissolution Enhancement of Furosemide by Solid Dispersion Technique Using Different Polymer. Journal of Pharmacy and Nutrition Sciences, 9(6), 329–338.


The oral route of drug administration is the most common and preferred method of delivery due to convenience and ease of ingestion. The objective of this study is to determine the dissolution enhancement quality of various polymers to Furosemide. Furosemide was selected as the model drug because it is therapeutically extremely important, having very low aqueous solubility and dissolution rate, but they are well permeable through membranes of the gastro-intestinal tract. Solid dispersions of Furosemide were also prepared by fusion method and solvent evaporation method. In this study, the effectiveness of the two methods for furosemide was investigated and compared while the effect of polymer on the dissolution kinetics of the drug was also observed. Poloxamer (two grades of Poloxamer; poloxamer 188 and poloxamer 407 were used in this study ), PEG and HPMC were expected to raise the dissolution rate of the poorly water-soluble furosemide and given its good permeation through GI membrane, to increase their oral bioavailability. To enhance the dissolution and efficacy of furosemide, Poloxamer188, PEG6000, and HPMC 6cps were used in different quantities. This work examined the influence of polymers such as Poloxamer 188 & 407, PEG6000 and HPMC 6cps in different amounts on release profile of furosemide. Through the dissolution studies, the in vitro release profile of the drug formulations was evaluated. An improved in vitro dissolution was obtained in all the systems.


Allen LVJ, Yanchick VA, Maness DD. Dissolution rates of corticosteriods utilizing sugar glass dispersions. J Pharm Sci 1977; 66(4): 494-496.

Shah N, Sandhu H, Choi DS, Chokshi H, Malick AW. Theoretical Considerations in Developing Amorphous Solid Dispersions: in Amorphous Solid Dispersions: Theory and Practice, Springer-Verlag New York 2014; 1st Ed.: 91-122.

Boles Ponto LL, Schoenwald RD. Furosemide: a pharmacokinetic / pharmacodynamic review part I. Clin Pharmacokinet 1990; 18: 381-408.

Ozdmir N, Ordu S. Improvement of dissolution properties of furosemide by complexation with cyclodextrin. Drug Dev Ind Pharm 1998; 24(1): 19-25.

El-Gazayerly ON. Characterization and evaluation of tenoxicam coprecipitates. Drug Dev Ind Pharm 2000; 26: 925-930.

Yamashita K, Nakate T, Okimoto KA. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 2003; 267: 79-91.

Makiko F, Hideko O, Yu suke S, Honami T, Masuo K, Yoshiteru W. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005; 293: 145-153.

Loganathan S, Maimaran S, Rajasekaran A, Reddy MVP, Sulaiman A. The effect of solid dispersions on (solubility) dissolution rate of ibuprofen. The Eastern Pharmacist 2000; 513: 115-116.

Hirasawa NI, Shise S, Miyata H, Danjo K. Physiochemical characteristics and drug release studies of nilvadipine solid dispersions using water insoluble polymer as carrier Drug. Dev Ind Pharm 2003; 29(3): 339-344.

Wadke DA, Serajuddin ATM, Jacobson H. Preformulation testing. In Pharmaceutical Dosage Forms: Tablets, Lieberman HA, Lachman L, Schwartz JB, Eds. Marcel Dekker: New York, 1989; Vol. 1: pp. 1-73

Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull 1961; 9: 866-872.

Goldberg AH, Galbaldi M, Kanig KL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures III. Experimental evaluation of griseofulvin-succinic acid solution. J Pharm Sci 1966; 55: 487-492.

Boles Ponto LL, Schoenwald RD. Furosemide: a pharmacokinetic / pharmacodynamic review part II. Clin Pharmacokinet 1990; 18(6): 460-471.

Asif F, Sultana T, Sohel MD, Sumon MHU, Kawsar MH, Islam MA. In Vitro Dissolution Pattern of Metronidazole Film Coated Tablet in Presence of Fruit Juice. American Journal of Pharmacological Sciences 2014; 2(2): 32-36.

Siahi-Shadbad MR, Ghanbarzadeh S, Barzegar-Jalali M, Valizadeh H, Taherpoor A, Mohammadi G, Barzegar-Jalali A, Adibkia K. Development and Characterization of Solid Dispersion for Dissolution Improvement of Furosemide by Cogrinding Method. Adv Pharm Bull 2014; 4(4): 391-399.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2019 Tanvir Halim , Nilufa Haque , Md. Didaruzzaman Sohel , Rajibul Islam Khan , Mohammad Menhaj Ovi , Labiba Amal  , Md. Hassan Kawsar